Since the accumulation of tumor-specific CTLs in the tumor microenvironment positively correlates with better clinical outcomes of cancer immunotherapies25, the infiltrates of CD8+ cells were analyzed by immunohistochemistry. This evidence concerns the gene CD8A and cancer.